Global Trastuzumab Biosimilar Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 179178
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Trastuzumab Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Trastuzumab Biosimilar size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Trastuzumab Biosimilar market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Trastuzumab Biosimilar market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Adjuvant Breast Cancer

Metastatic Breast Cancer

Metastatic Gastric Cancer

Others

Market segment by Application can be divided into

Hospital Pharmacy

Online Pharmacy

The key market players for global Trastuzumab Biosimilar market are listed below:

Amgen Inc.

Pfizer Inc

Samsung Bioepis

Merck & Co.

Biocon Limited

Teva Pharmaceutical

Genentech

Mundipharma

Celltrion

Henlius

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Trastuzumab Biosimilar product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Trastuzumab Biosimilar, with price, sales, revenue and global market share of Trastuzumab Biosimilar in 2018 and 2019.

Chapter 3, the Trastuzumab Biosimilar competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Trastuzumab Biosimilar breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Trastuzumab Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Trastuzumab Biosimilar sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Trastuzumab Biosimilar Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Trastuzumab Biosimilar Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Adjuvant Breast Cancer

1.2.3 Metastatic Breast Cancer

1.2.4 Metastatic Gastric Cancer

1.2.5 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global Trastuzumab Biosimilar Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Hospital Pharmacy

1.3.3 Online Pharmacy

1.4 Global Trastuzumab Biosimilar Market Size & Forecast

1.4.1 Global Trastuzumab Biosimilar Sales in Value (2016-2026))

1.4.2 Global Trastuzumab Biosimilar Sales in Volume (2016-2026)

1.4.3 Global Trastuzumab Biosimilar Price by Type (2016-2026) & (US$/Unit)

1.5 Global Trastuzumab Biosimilar Production Capacity Analysis

1.5.1 Global Trastuzumab Biosimilar Total Production Capacity (2016-2026)

1.5.2 Global Trastuzumab Biosimilar Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Trastuzumab Biosimilar Market Drivers

1.6.2 Trastuzumab Biosimilar Market Restraints

1.6.3 Trastuzumab Biosimilar Trends Analysis

2 Manufacturers Profiles

2.1 Amgen Inc.

2.1.1 Amgen Inc. Details

2.1.2 Amgen Inc. Major Business

2.1.3 Amgen Inc. Trastuzumab Biosimilar Product and Services

2.1.4 Amgen Inc. Trastuzumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Pfizer Inc

2.2.1 Pfizer Inc Details

2.2.2 Pfizer Inc Major Business

2.2.3 Pfizer Inc Trastuzumab Biosimilar Product and Services

2.2.4 Pfizer Inc Trastuzumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Samsung Bioepis

2.3.1 Samsung Bioepis Details

2.3.2 Samsung Bioepis Major Business

2.3.3 Samsung Bioepis Trastuzumab Biosimilar Product and Services

2.3.4 Samsung Bioepis Trastuzumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Merck & Co.

2.4.1 Merck & Co. Details

2.4.2 Merck & Co. Major Business

2.4.3 Merck & Co. Trastuzumab Biosimilar Product and Services

2.4.4 Merck & Co. Trastuzumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Biocon Limited

2.5.1 Biocon Limited Details

2.5.2 Biocon Limited Major Business

2.5.3 Biocon Limited Trastuzumab Biosimilar Product and Services

2.5.4 Biocon Limited Trastuzumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Teva Pharmaceutical

2.6.1 Teva Pharmaceutical Details

2.6.2 Teva Pharmaceutical Major Business

2.6.3 Teva Pharmaceutical Trastuzumab Biosimilar Product and Services

2.6.4 Teva Pharmaceutical Trastuzumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Genentech

2.7.1 Genentech Details

2.7.2 Genentech Major Business

2.7.3 Genentech Trastuzumab Biosimilar Product and Services

2.7.4 Genentech Trastuzumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Mundipharma

2.8.1 Mundipharma Details

2.8.2 Mundipharma Major Business

2.8.3 Mundipharma Trastuzumab Biosimilar Product and Services

2.8.4 Mundipharma Trastuzumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Celltrion

2.9.1 Celltrion Details

2.9.2 Celltrion Major Business

2.9.3 Celltrion Trastuzumab Biosimilar Product and Services

2.9.4 Celltrion Trastuzumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Henlius

2.10.1 Henlius Details

2.10.2 Henlius Major Business

2.10.3 Henlius Trastuzumab Biosimilar Product and Services

2.10.4 Henlius Trastuzumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Trastuzumab Biosimilar Sales by Manufacturer

3.1 Global Trastuzumab Biosimilar Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Trastuzumab Biosimilar Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Trastuzumab Biosimilar

3.4 Market Concentration Rate

3.4.1 Top 3 Trastuzumab Biosimilar Manufacturer Market Share

3.4.2 Top 6 Trastuzumab Biosimilar Manufacturer Market Share

3.5 Global Trastuzumab Biosimilar Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Trastuzumab Biosimilar Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Trastuzumab Biosimilar Market Size by Region

4.1.1 Global Trastuzumab Biosimilar Sales in Volume by Region (2016-2026)

4.1.2 Global Trastuzumab Biosimilar Revenue by Region (2016-2026)

4.2 North America Trastuzumab Biosimilar Revenue (2016-2026)

4.3 Europe Trastuzumab Biosimilar Revenue (2016-2026)

4.4 Asia-Pacific Trastuzumab Biosimilar Revenue (2016-2026)

4.5 South America Trastuzumab Biosimilar Revenue (2016-2026)

4.6 Middle East and Africa Trastuzumab Biosimilar Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Trastuzumab Biosimilar Sales in Volume by Type (2016-2026)

5.2 Global Trastuzumab Biosimilar Revenue by Type (2016-2026)

5.3 Global Trastuzumab Biosimilar Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Trastuzumab Biosimilar Sales in Volume by Application (2016-2026)

6.2 Global Trastuzumab Biosimilar Revenue by Application (2016-2026)

6.3 Global Trastuzumab Biosimilar Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Trastuzumab Biosimilar Sales by Type (2016-2026)

7.2 North America Trastuzumab Biosimilar Sales by Application (2016-2026)

7.3 North America Trastuzumab Biosimilar Market Size by Country

7.3.1 North America Trastuzumab Biosimilar Sales in Volume by Country (2016-2026)

7.3.2 North America Trastuzumab Biosimilar Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Trastuzumab Biosimilar Sales by Type (2016-2026)

8.2 Europe Trastuzumab Biosimilar Sales by Application (2016-2026)

8.3 Europe Trastuzumab Biosimilar Market Size by Country

8.3.1 Europe Trastuzumab Biosimilar Sales in Volume by Country (2016-2026)

8.3.2 Europe Trastuzumab Biosimilar Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Trastuzumab Biosimilar Sales by Type (2016-2026)

9.2 Asia-Pacific Trastuzumab Biosimilar Sales by Application (2016-2026)

9.3 Asia-Pacific Trastuzumab Biosimilar Market Size by Region

9.3.1 Asia-Pacific Trastuzumab Biosimilar Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Trastuzumab Biosimilar Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Trastuzumab Biosimilar Sales by Type (2016-2026)

10.2 South America Trastuzumab Biosimilar Sales by Application (2016-2026)

10.3 South America Trastuzumab Biosimilar Market Size by Country

10.3.1 South America Trastuzumab Biosimilar Sales in Volume by Country (2016-2026)

10.3.2 South America Trastuzumab Biosimilar Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Trastuzumab Biosimilar Sales by Type (2016-2026)

11.2 Middle East & Africa Trastuzumab Biosimilar Sales by Application (2016-2026)

11.3 Middle East & Africa Trastuzumab Biosimilar Market Size by Country

11.3.1 Middle East & Africa Trastuzumab Biosimilar Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Trastuzumab Biosimilar Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Trastuzumab Biosimilar Typical Distributors

12.3 Trastuzumab Biosimilar Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Trastuzumab Biosimilar Revenue by Type, (USD Million), 2021-2026

Table 2. Global Trastuzumab Biosimilar Revenue by Application, (USD Million), 2021-2026

Table 3. Amgen Inc. Basic Information, Manufacturing Base and Competitors

Table 4. Amgen Inc. Major Business

Table 5. Amgen Inc. Trastuzumab Biosimilar Product and Services

Table 6. Amgen Inc. Trastuzumab Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Pfizer Inc Basic Information, Manufacturing Base and Competitors

Table 8. Pfizer Inc Major Business

Table 9. Pfizer Inc Trastuzumab Biosimilar Product and Services

Table 10. Pfizer Inc Trastuzumab Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Samsung Bioepis Basic Information, Manufacturing Base and Competitors

Table 12. Samsung Bioepis Major Business

Table 13. Samsung Bioepis Trastuzumab Biosimilar Product and Services

Table 14. Samsung Bioepis Trastuzumab Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Merck & Co. Basic Information, Manufacturing Base and Competitors

Table 16. Merck & Co. Major Business

Table 17. Merck & Co. Trastuzumab Biosimilar Product and Services

Table 18. Merck & Co. Trastuzumab Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Biocon Limited Basic Information, Manufacturing Base and Competitors

Table 20. Biocon Limited Major Business

Table 21. Biocon Limited Trastuzumab Biosimilar Product and Services

Table 22. Biocon Limited Trastuzumab Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 24. Teva Pharmaceutical Major Business

Table 25. Teva Pharmaceutical Trastuzumab Biosimilar Product and Services

Table 26. Teva Pharmaceutical Trastuzumab Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Genentech Basic Information, Manufacturing Base and Competitors

Table 28. Genentech Major Business

Table 29. Genentech Trastuzumab Biosimilar Product and Services

Table 30. Genentech Trastuzumab Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Mundipharma Basic Information, Manufacturing Base and Competitors

Table 32. Mundipharma Major Business

Table 33. Mundipharma Trastuzumab Biosimilar Product and Services

Table 34. Mundipharma Trastuzumab Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Celltrion Basic Information, Manufacturing Base and Competitors

Table 36. Celltrion Major Business

Table 37. Celltrion Trastuzumab Biosimilar Product and Services

Table 38. Celltrion Trastuzumab Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Henlius Basic Information, Manufacturing Base and Competitors

Table 40. Henlius Major Business

Table 41. Henlius Trastuzumab Biosimilar Product and Services

Table 42. Henlius Trastuzumab Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Global Trastuzumab Biosimilar Sales by Manufacturer (2019-2021e) & (K Units)

Table 44. Global Trastuzumab Biosimilar Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 45. Market Position of Manufacturers in Trastuzumab Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 46. Global Trastuzumab Biosimilar Production Capacity by Company, (K Units): 2020 VS 2021

Table 47. Head Office and Trastuzumab Biosimilar Production Site of Key Manufacturer

Table 48. Trastuzumab Biosimilar New Entrant and Capacity Expansion Plans

Table 49. Trastuzumab Biosimilar Mergers & Acquisitions in the Past Five Years

Table 50. Global Trastuzumab Biosimilar Sales by Region (2016-2021e) & (K Units)

Table 51. Global Trastuzumab Biosimilar Sales by Region (2021-2026) & (K Units)

Table 52. Global Trastuzumab Biosimilar Revenue by Region (2016-2021e) & (USD Million)

Table 53. Global Trastuzumab Biosimilar Revenue by Region (2021-2026) & (USD Million)

Table 54. Global Trastuzumab Biosimilar Sales by Type (2016-2021e) & (K Units)

Table 55. Global Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units)

Table 56. Global Trastuzumab Biosimilar Revenue by Type (2016-2021e) & (USD Million)

Table 57. Global Trastuzumab Biosimilar Revenue by Type (2021-2026) & (USD Million)

Table 58. Global Trastuzumab Biosimilar Price by Type (2016-2021e) & (US$/Unit)

Table 59. Global Trastuzumab Biosimilar Price by Type (2021-2026) & (US$/Unit)

Table 60. Global Trastuzumab Biosimilar Sales by Application (2016-2021e) & (K Units)

Table 61. Global Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units)

Table 62. Global Trastuzumab Biosimilar Revenue by Application (2016-2021e) & (USD Million)

Table 63. Global Trastuzumab Biosimilar Revenue by Application (2021-2026) & (USD Million)

Table 64. Global Trastuzumab Biosimilar Price by Application (2016-2021e) & (US$/Unit)

Table 65. Global Trastuzumab Biosimilar Price by Application (2021-2026) & (US$/Unit)

Table 66. North America Trastuzumab Biosimilar Sales by Country (2016-2021e) & (K Units)

Table 67. North America Trastuzumab Biosimilar Sales by Country (2021-2026) & (K Units)

Table 68. North America Trastuzumab Biosimilar Revenue by Country (2016-2021e) & (USD Million)

Table 69. North America Trastuzumab Biosimilar Revenue by Country (2021-2026) & (USD Million)

Table 70. North America Trastuzumab Biosimilar Sales by Type (2016-2021e) & (K Units)

Table 71. North America Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units)

Table 72. North America Trastuzumab Biosimilar Sales by Application (2016-2021e) & (K Units)

Table 73. North America Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units)

Table 74. Europe Trastuzumab Biosimilar Sales by Country (2016-2021e) & (K Units)

Table 75. Europe Trastuzumab Biosimilar Sales by Country (2021-2026) & (K Units)

Table 76. Europe Trastuzumab Biosimilar Revenue by Country (2016-2021e) & (USD Million)

Table 77. Europe Trastuzumab Biosimilar Revenue by Country (2021-2026) & (USD Million)

Table 78. Europe Trastuzumab Biosimilar Sales by Type (2016-2021e) & (K Units)

Table 79. Europe Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units)

Table 80. Europe Trastuzumab Biosimilar Sales by Application (2016-2021e) & (K Units)

Table 81. Europe Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units)

Table 82. Asia-Pacific Trastuzumab Biosimilar Sales by Region (2016-2021e) & (K Units)

Table 83. Asia-Pacific Trastuzumab Biosimilar Sales by Region (2021-2026) & (K Units)

Table 84. Asia-Pacific Trastuzumab Biosimilar Revenue by Region (2016-2021e) & (USD Million)

Table 85. Asia-Pacific Trastuzumab Biosimilar Revenue by Region (2021-2026) & (USD Million)

Table 86. Asia-Pacific Trastuzumab Biosimilar Sales by Type (2016-2021e) & (K Units)

Table 87. Asia-Pacific Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units)

Table 88. Asia-Pacific Trastuzumab Biosimilar Sales by Application (2016-2021e) & (K Units)

Table 89. Asia-Pacific Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units)

Table 90. South America Trastuzumab Biosimilar Sales by Country (2016-2021e) & (K Units)

Table 91. South America Trastuzumab Biosimilar Sales by Country (2021-2026) & (K Units)

Table 92. South America Trastuzumab Biosimilar Revenue by Country (2016-2021e) & (USD Million)

Table 93. South America Trastuzumab Biosimilar Revenue by Country (2021-2026) & (USD Million)

Table 94. South America Trastuzumab Biosimilar Sales by Type (2016-2021e) & (K Units)

Table 95. South America Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units)

Table 96. South America Trastuzumab Biosimilar Sales by Application (2016-2021e) & (K Units)

Table 97. South America Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units)

Table 98. Middle East & Africa Trastuzumab Biosimilar Sales by Country (2016-2021e) & (K Units)

Table 99. Middle East & Africa Trastuzumab Biosimilar Sales by Country (2021-2026) & (K Units)

Table 100. Middle East & Africa Trastuzumab Biosimilar Revenue by Country (2016-2021e) & (USD Million)

Table 101. Middle East & Africa Trastuzumab Biosimilar Revenue by Country (2021-2026) & (USD Million)

Table 102. Middle East & Africa Trastuzumab Biosimilar Sales by Type (2016-2021e) & (K Units)

Table 103. Middle East & Africa Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units)

Table 104. Middle East & Africa Trastuzumab Biosimilar Sales by Application (2016-2021e) & (K Units)

Table 105. Middle East & Africa Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units)

Table 106. Direct Channel Pros & Cons

Table 107. Indirect Channel Pros & Cons

Table 108. Trastuzumab Biosimilar Typical Distributors

Table 109. Trastuzumab Biosimilar Typical Customers

List of Figures

Figure 1. Trastuzumab Biosimilar Picture

Figure 2. Global Trastuzumab Biosimilar Sales Market Share by Type in 2020

Figure 3. Adjuvant Breast Cancer

Figure 4. Metastatic Breast Cancer

Figure 5. Metastatic Gastric Cancer

Figure 6. Others

Figure 7. Global Trastuzumab Biosimilar Sales Market Share by Application in 2020

Figure 8. Hospital Pharmacy

Figure 9. Online Pharmacy

Figure 10. Global Trastuzumab Biosimilar Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 11. Global Trastuzumab Biosimilar Market Size and Forecast (2016-2026) & (USD Million)

Figure 12. Global Trastuzumab Biosimilar Sales (2016-2026) & (K Units)

Figure 13. Global Trastuzumab Biosimilar Price by Type (2016-2026) & (US$/Unit)

Figure 14. Global Trastuzumab Biosimilar Production Capacity (2016-2026) & (K Units)

Figure 15. Global Trastuzumab Biosimilar Production Capacity by Geographic Region: 2020 VS 2021

Figure 16. Trastuzumab Biosimilar Market Drivers

Figure 17. Trastuzumab Biosimilar Market Restraints

Figure 18. Trastuzumab Biosimilar Market Trends

Figure 19. Global Trastuzumab Biosimilar Sales Market Share by Manufacturer in 2020

Figure 20. Global Trastuzumab Biosimilar Revenue Market Share by Manufacturer in 2020

Figure 21. Trastuzumab Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. Top 3 Trastuzumab Biosimilar Manufacturer (Revenue) Market Share in 2020

Figure 23. Top 6 Trastuzumab Biosimilar Manufacturer (Revenue) Market Share in 2020

Figure 24. Global Trastuzumab Biosimilar Sales Market Share by Region (2016-2026)

Figure 25. Global Trastuzumab Biosimilar Revenue Market Share by Region (2016-2026)

Figure 26. North America Trastuzumab Biosimilar Revenue (2016-2026) & (USD Million)

Figure 27. Europe Trastuzumab Biosimilar Revenue (2016-2026) & (USD Million)

Figure 28. Asia-Pacific Trastuzumab Biosimilar Revenue (2016-2026) & (USD Million)

Figure 29. South America Trastuzumab Biosimilar Revenue (2016-2026) & (USD Million)

Figure 30. Middle East & Africa Trastuzumab Biosimilar Revenue (2016-2026) & (USD Million)

Figure 31. Global Trastuzumab Biosimilar Sales Market Share by Type (2016-2026)

Figure 32. Global Trastuzumab Biosimilar Revenue Market Share by Type (2016-2026)

Figure 33. Global Trastuzumab Biosimilar Price by Type (2016-2026) & (US$/Unit)

Figure 34. Global Trastuzumab Biosimilar Sales Market Share by Application (2016-2026)

Figure 35. Global Trastuzumab Biosimilar Revenue Market Share by Application (2016-2026)

Figure 36. Global Trastuzumab Biosimilar Price by Application (2016-2026) & (US$/Unit)

Figure 37. North America Trastuzumab Biosimilar Sales Market Share by Type (2016-2026)

Figure 38. North America Trastuzumab Biosimilar Sales Market Share by Application (2016-2026)

Figure 39. North America Trastuzumab Biosimilar Sales Market Share by Country (2016-2026)

Figure 40. North America Trastuzumab Biosimilar Revenue Market Share by Country (2016-2026)

Figure 41. United States Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Canada Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Mexico Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Europe Trastuzumab Biosimilar Sales Market Share by Type (2016-2026)

Figure 45. Europe Trastuzumab Biosimilar Sales Market Share by Application (2016-2026)

Figure 46. Europe Trastuzumab Biosimilar Sales Market Share by Country (2016-2026)

Figure 47. Europe Trastuzumab Biosimilar Revenue Market Share by Country (2016-2026)

Figure 48. Germany Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. France Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. United Kingdom Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Russia Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Italy Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Asia-Pacific Trastuzumab Biosimilar Sales Market Share by Region (2016-2026)

Figure 54. Asia-Pacific Trastuzumab Biosimilar Sales Market Share by Application (2016-2026)

Figure 55. Asia-Pacific Trastuzumab Biosimilar Sales Market Share by Region (2016-2026)

Figure 56. Asia-Pacific Trastuzumab Biosimilar Revenue Market Share by Region (2016-2026)

Figure 57. China Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Japan Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Korea Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. India Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Southeast Asia Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Australia Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South America Trastuzumab Biosimilar Sales Market Share by Type (2016-2026)

Figure 64. South America Trastuzumab Biosimilar Sales Market Share by Application (2016-2026)

Figure 65. South America Trastuzumab Biosimilar Sales Market Share by Country (2016-2026)

Figure 66. South America Trastuzumab Biosimilar Revenue Market Share by Country (2016-2026)

Figure 67. Brazil Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Argentina Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Middle East & Africa Trastuzumab Biosimilar Sales Market Share by Type (2016-2026)

Figure 70. Middle East & Africa Trastuzumab Biosimilar Sales Market Share by Application (2016-2026)

Figure 71. Middle East & Africa Trastuzumab Biosimilar Sales Market Share by Country (2016-2026)

Figure 72. Middle East & Africa Trastuzumab Biosimilar Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Egypt Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Saudi Arabia Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. South Africa Trastuzumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Sales Channel: Direct Channel vs Indirect Channel

Figure 78. Methodology

Figure 79. Research Process and Data Source